Description:
Dapagliflozin is a selective, orally active inhibitor of the renal sodium-glucose co-transporter type 2 (SGLT2) in development for the treatment of type 2 diabetes mellitus (T2DM).
- Molecular Weight: 408.87
- Molecular Formula: C21H25ClO6
Purity: >98%
Canonical SMILES:
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl
InChI:
InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1
InChIKey: JVHXJTBJCFBINQ-ADAARDCZSA-N
- Melting Point: 55-58°C
- Solubility: Soluble in DMSO, Methanol
- Appearance: White to Pale Yellow Solid
- Storage: Store at -20°C
Synonyms:
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; BMS 512148
More details are to be found on supplier website
